Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Assets Average (2020 - 2025)

Mirum Pharmaceuticals (MIRM) has 6 years of Assets Average data on record, last reported at $814.0 million in Q4 2025.

  • For Q4 2025, Assets Average rose 21.61% year-over-year to $814.0 million; the TTM value through Dec 2025 reached $814.0 million, up 21.61%, while the annual FY2025 figure was $756.8 million, 14.89% up from the prior year.
  • Assets Average reached $814.0 million in Q4 2025 per MIRM's latest filing, up from $755.5 million in the prior quarter.
  • Across five years, Assets Average topped out at $814.0 million in Q4 2025 and bottomed at $231.6 million in Q1 2021.
  • Average Assets Average over 5 years is $488.1 million, with a median of $467.8 million recorded in 2023.
  • The widest YoY moves for Assets Average: up 89.18% in 2024, down 3.19% in 2024.
  • A 5-year view of Assets Average shows it stood at $264.9 million in 2021, then surged by 35.38% to $358.6 million in 2022, then soared by 80.87% to $648.6 million in 2023, then grew by 3.19% to $669.3 million in 2024, then grew by 21.61% to $814.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $814.0 million in Q4 2025, $755.5 million in Q3 2025, and $708.0 million in Q2 2025.